1. Home
  2. BIAF vs GREE Comparison

BIAF vs GREE Comparison

Compare BIAF & GREE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIAF
  • GREE
  • Stock Information
  • Founded
  • BIAF 2014
  • GREE 1937
  • Country
  • BIAF United States
  • GREE United States
  • Employees
  • BIAF N/A
  • GREE N/A
  • Industry
  • BIAF Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • GREE Investment Bankers/Brokers/Service
  • Sector
  • BIAF Health Care
  • GREE Finance
  • Exchange
  • BIAF Nasdaq
  • GREE Nasdaq
  • Market Cap
  • BIAF 12.2M
  • GREE 9.8M
  • IPO Year
  • BIAF 2022
  • GREE N/A
  • Fundamental
  • Price
  • BIAF $0.49
  • GREE $0.80
  • Analyst Decision
  • BIAF Hold
  • GREE Strong Buy
  • Analyst Count
  • BIAF 1
  • GREE 1
  • Target Price
  • BIAF N/A
  • GREE $4.00
  • AVG Volume (30 Days)
  • BIAF 28.5M
  • GREE 149.7K
  • Earning Date
  • BIAF 05-14-2025
  • GREE 05-14-2025
  • Dividend Yield
  • BIAF N/A
  • GREE N/A
  • EPS Growth
  • BIAF N/A
  • GREE N/A
  • EPS
  • BIAF N/A
  • GREE N/A
  • Revenue
  • BIAF $9,362,022.00
  • GREE $59,533,000.00
  • Revenue This Year
  • BIAF N/A
  • GREE N/A
  • Revenue Next Year
  • BIAF $19.99
  • GREE N/A
  • P/E Ratio
  • BIAF N/A
  • GREE N/A
  • Revenue Growth
  • BIAF 269.68
  • GREE N/A
  • 52 Week Low
  • BIAF $0.24
  • GREE $0.58
  • 52 Week High
  • BIAF $3.16
  • GREE $3.84
  • Technical
  • Relative Strength Index (RSI)
  • BIAF 48.21
  • GREE 54.89
  • Support Level
  • BIAF $0.46
  • GREE $0.61
  • Resistance Level
  • BIAF $0.58
  • GREE $0.69
  • Average True Range (ATR)
  • BIAF 0.11
  • GREE 0.07
  • MACD
  • BIAF -0.01
  • GREE 0.02
  • Stochastic Oscillator
  • BIAF 8.65
  • GREE 75.52

About BIAF bioAffinity Technologies Inc.

bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.

About GREE Greenidge Generation Holdings Inc.

Greenidge Generation Holdings Inc owns and operates a vertically integrated cryptocurrency data center and power generation company. The company owns and operates facilities at two locations: the Town of Torrey, New York, and Spartanburg, South Carolina. The cryptocurrency data center operations generate revenue in the form of bitcoin by earning bitcoin as rewards and transaction fees for supporting the bitcoin network with application-specific integrated circuit computers (ASICs or miners) owned or leased by the company.

Share on Social Networks: